Cetuximab Plus Platinum-Based Chemotherapy in Head and Neck Squamous Cell Carcinoma: A Randomized, Double-Blind Safety Study Comparing Cetuximab Produced From Two Manufacturing Processes Using the EXTREME Study Regimen

BMC Cancer - United Kingdom
doi 10.1186/s12885-016-2064-0

Related search